 | Not displayed, CONTACT the Zenopa Account Manager Zenopa on 01494 818 000 or zenopa@zenopa.com for CURRENT and future vacancies.
|  |  | Previous Jobs
Key Account Manager
Location: Dudley, Hereford, Worc
| |
|  | Recordati Pharmaceuticals Jobs Profile | About Us
Recordati, established in 1926, is a European pharmaceutical group, listed on the Italian Stock Exchange (Reuters RECI.MI, Bloomberg REC IM, ISIN IT 0003828271), dedicated to the research, development, manufacturing and marketing of pharmaceuticals, with headquarters in Milan, Italy, operations in the main European countries, and a total staff of over 2,200. A European field force of over 1,100 medical representatives promotes a wide range of innovative pharmaceuticals, both proprietary and under license, in a number of therapeutic areas. Recordati’s current and growing coverage of the European pharmaceutical market makes it a partner of choice for new product licenses from companies which do not have European marketing organizations. Recordati is committed to the research of new drug entities within the cardiovascular and urogenital therapeutic areas in which its research team has proven scientific competence and a track record of discovery and development of original drugs, the most recent of which, lercanidipine, a latest generation calcium channel blocker for the treatment of hypertension, is the company’s leading product. Consolidated revenue for 2006 was € 576.2 million, operating income was € 120.3 million and net income was € 74.0 million.
Our Mission
Recordati is a European specialty pharmaceutical group dedicated to partnering, discovering and developing innovative, value-added products that improve the quality of life and help people to enjoy longer, healthier and more productive lives.
Our success as a healthcare enterprise will benefit not only the patients whose needs we meet but all our stakeholders whom we serve – our customers, our shareholders, our employees and their families.
Products
Recordati offers both prescription and OTC products in a wide range of therapeutic areas.
Recordati’s flagship product is ZANIDIP® (lercanidipine), a latest generation calcium-channel blocker for the treatment of hypertension. It is a lipophilic dihydropyridine, discovered and entirely developed by Recordati, with the following characteristics: natural once a day, potent, long-lasting vasodilatory activity, highly vasoselective with gradual onset, smooth and uniform blood pressure lowering activity and improved tolerability over other dihydropyridines.
We offer a wide range of innovative pharmaceuticals in specifc therapeutic areas:
Antibiotics and Antivirals
Cardiovascular
Central nervous system
Dermatological
Gastroenterology
Genito-urinary system
Muscolo-skeletal disorders and pain therapy
Obstetics and Gynaecology
OTC (non-prescription pharmaceuticals) |  |
|
| | Zenopa
Recordati Pharmaceuticals Account Manager
01494 818 000
(Mon to Fri 0830 to 1800 hours)
zenopa@zenopa.com
| |
|
